close

Transforming DNA repair errors into assets

Transforming DNA repair errors into assets A new bioinformatics tool, MHcut, developed by researchers in Kyoto, Japan, and Montreal, Canada, reveals that a natural repair system for DNA damage, microhomology-mediated end joining, is probably far more common in humans than originally assumed. Using MHcut and commercial genome-editing technology, the researchers created…..

NEW: LANDSCAPE IN GENE THERAPY COMPANIES 2019

  BioPharmAnalyses and OctopusyX BioConsulting are proud to announce the launch of their up-dated and enriched 2019 edition of their report entitled “Landscape… in Gene Therapy Companies”.  This report provides you with an in-depth analysis of more than 230 companies involved in this expanding field. (UPDATED SEP 2019)   In…..

NEW: LANDSCAPE IN GENE THERAPY COMPANIES

Gene Therapy is a rapidly and obviously evolving field that is now definitively recognized as a well-acknowledged major medical and scientific area. BioPharmAnalyses is proud to announce the launch of its new global commercial report "Landscape in Gene Therapy Companies". This is the first such report that provides you with an actually updated information and an accurate international mapping…..

« La thérapie génique va trouver sa place dans l’arsenal thérapeutique » – Entretien avec Serge Braun, directeur scientifique de l’AFM-Telethon

 Vingt-cinq ans après les premiers essais de thérapie génique chez l’homme, Serge Braun, directeur scientifique de l’AFM-Telethon (photo), fait le point sur la situation actuelle de ces nouveaux traitements qui intéressent maintenant un nombre croissant de big pharma et de biotech. BioPharmAnalyses : Quelles sont les technologies les plus utilisées…..